Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ashraf Amlani is active.

Publication


Featured researches published by Ashraf Amlani.


Journal of Natural Products | 2011

Turnagainolides A and B,Cyclic Depsipeptides Produced in Culture by a Bacillus sp.: Isolation, Structure Elucidation, and Synthesis

Dehai Li; Gavin Carr; Yonghong Zhang; David E. Williams; Ashraf Amlani; Helen Bottriell; Alice L.-F. Mui; Raymond J. Andersen

Two new cyclic depsipeptides, turnagainolides A (1) and B (2), have been isolated from laboratory cultures of a marine isolate of Bacillus sp. The structures of 1 and 2, which are simply epimers at the site of macrolactonization, were elucidated by analysis of NMR data and chemical degradation. A total synthesis of the turnagainolides confirmed their structures. Turnagainolide B (2) showed activity in a SHIP1 activation assay.


Australian Journal of Chemistry | 2010

Australin E Isolated from the Soft Coral Cladiella sp. Collected in Pohnpei Activates the Inositol 5-Phosphatase SHIP1

David E. Williams; Ashraf Amlani; Ariyanti S. Dewi; Brian O. Patrick; Leen P. van Ofwegen; Alice L.-F. Mui; Raymond J. Andersen

Four new diterpenoids, australins E–H (1–4), have been isolated from the marine soft coral Cladiella sp. collected in Pohnpei. The structures of 1–4 were elucidated by analysis of their NMR and mass spectrometry data combined with an X-ray diffraction analysis of australin E (1). Australin E (1) activates the inositol 5-phosphatase SHIP1 in vitro.


Harm Reduction Journal | 2016

Qualitative assessment of take-home naloxone program participant and law enforcement interactions in British Columbia

Andrew Deonarine; Ashraf Amlani; Graham Ambrose; Jane A. Buxton

BackgroundThe British Columbia take-home naloxone (BCTHN) program has been in operation since 2012 and has resulted in the successful reversal of over 581 opioid overdoses. The study aims to explore BCTHN program participant perspectives about the program, barriers to participants contacting emergency services (calling “911”) during an overdose, and perspectives of law enforcement officials on naloxone administration by police officers.MethodsTwo focus groups and four individual interviews were conducted with BCTHN program participants; interviews with two law enforcement officials were also conducted. Qualitative analysis of all transcripts was performed.ResultsPositive themes about the BCTHN program from participants included easy to understand training, correcting misperceptions in the community, and positive interactions with emergency services. Potential barriers to contacting emergency services during an overdose include concerns about being arrested for outstanding warrants or for other illegal activities (such as drug possession) and confiscation of kits. Law enforcement officials noted that warrants were complex situational issues, kits would normally not be confiscated, and admitted arrests for drug possession or other activities may not serve the public good in an overdose situation. Law enforcement officials were concerned about legal liability and jurisdictional/authorization issues if naloxone administration privileges were expanded to police.ConclusionsProgram participants and law enforcement officials expressed differing perspectives about warrants, kit confiscation, and arrests. Facilitating communication between BCTHN program participants and other stakeholders may address some of the confusion and remove potential barriers to further improving program outcomes. Naloxone administration by law enforcement would require policies to address jurisdiction/authorization and liability issues.


BMJ Open | 2016

Predictors of seeking emergency medical help during overdose events in a provincial naloxone distribution programme: a retrospective analysis

Graham Ambrose; Ashraf Amlani; Jane A. Buxton

Objectives This study sought to identify factors that may be associated with help-seeking by witnesses during overdoses where naloxone is administered. Setting Overdose events occurred in and were reported from the five regional health authorities across British Columbia, Canada. Naloxone administration forms completed following overdose events were submitted to the British Columbia Take Home Naloxone programme. Participants All 182 reported naloxone administration events, reported by adult men and women and occurring between 31 August 2012 and 31 March 2015, were considered for inclusion in the analysis. Of these, 18 were excluded: 10 events which were reported by the person who overdosed, and 8 events for which completed forms did not indicate whether or not emergency medical help was sought. Primary and secondary outcome measures Seeking emergency medical help (calling 911), as reported by participants, was the sole outcome measure of this analysis. Results Medical help was sought (emergency services—911 called) in 89 (54.3%) of 164 overdoses where naloxone was administered. The majority of administration events occurred in private residences (50.6%) and on the street (23.4%), where reported rates of calling 911 were 27.5% and 81.1%, respectively. Overdoses occurring on the street (compared to private residence) were significantly associated with higher odds of calling 911 in multivariate analysis (OR=10.68; 95% CI 2.83 to 51.87; p<0.01), after adjusting for other variables. Conclusions Overdoses occurring on the street were associated with higher odds of seeking emergency medical help by responders. Further research is needed to determine if sex and stimulant use by the person who overdosed are associated with seeking emergency medical help. The results of this study will inform interventions within the British Columbia Take Home Naloxone programme and other jurisdictions to encourage seeking emergency medical help.


BMC Public Health | 2015

Reorienting risk to resilience: street-involved youth perspectives on preventing the transition to injection drug use

Kira Tozer; Despina Tzemis; Ashraf Amlani; Larissa Coser; Darlene Taylor; Natasha Van Borek; Elizabeth Saewyc; Jane A. Buxton

BackgroundThe Youth Injection Prevention (YIP) project aimed to identify factors associated with the prevention of transitioning to injection drug use (IDU) among street-involved youth (youth who had spent at least 3 consecutive nights without a fixed address or without their parents/caregivers in the previous six months) aged 16–24 years in Metro Vancouver, British Columbia.MethodsTen focus groups were conducted by youth collaborators (peer-researchers) with street-involved youth (n = 47) from November 2009-April 2010. Audio recordings and focus group observational notes were transcribed verbatim and emergent themes identified by open coding and categorizing.ResultsThrough ongoing data analysis we identified that youth produced risk and deficiency rather than resiliency-based answers. This enabled the questioning guide to be reframed into a strengths-based guide in a timely manner. Factors youth identified that prevented them from IDU initiation were grouped into three domains loosely derived from the risk environment framework: Individual (fear and self-worth), Social Environment (stigma and group norms – including street-entrenched adults who actively discouraged youth from IDU, support/inclusion, family/friend drug use and responsibilities), and Physical/Economic Environment (safe/engaging spaces). Engaging youth collaborators in the research ensured relevance and validity of the study.ConclusionParticipants emphasized having personal goals and ties to social networks, supportive family and role models, and the need for safe and stable housing as key to resiliency. Gaining the perspectives of street-involved youth on factors that prevent IDU provides a complementary perspective to risk-based studies and encourages strength-based approaches for coaching and care of at-risk youth and upon which prevention programs should be built.


Harm Reduction Journal | 2018

Pain as a risk factor for substance use: a qualitative study of people who use drugs in British Columbia, Canada

Pauline Voon; Alissa M. Greer; Ashraf Amlani; Cheri Newman; Charlene Burmeister; Jane A. Buxton

BackgroundPeople who use drugs have a significantly higher prevalence of chronic non-cancer pain compared to the general population, yet little is known about how various policy, economic, physical, and social environments may serve as risk or protective factors in the context of concurrent pain and substance use. Therefore, this study sought to explore perspectives, risks, and harms associated with pain among people who use drugs.MethodsThirteen focus group interviews were held across British Columbia, Canada, from July to September 2015. In total, 83 people who had lived experience with substance use participated in the study. Using an interpretive description approach, themes were conceptualized according to the Rhodes’ Risk Environment and patient-centered care frameworks.ResultsParticipants described how their experiences with inadequately managed pain in various policy, economic, physical, and social environments reinforced marginalization, such as restrictive policies, economic vulnerability, lack of access to socio-physical support systems, stigma from health professionals, and denial of pain medication leading to risky self-medication. Principles of patient-centered care were often not upheld, from a lack of recognition of patients as experts in understanding their unique pain needs and experiences, to an absence of shared power and decision-making, which often resulted in distrust of the patient-provider relationship.ConclusionsVarious risk environments and non-patient-centered interactions may contribute to an array of health and social harms in the context of inadequately managed pain among people who use drugs.


BMC Public Health | 2018

Participant, peer and PEEP: considerations and strategies for involving people who have used illicit substances as assistants and advisors in research

Alissa M. Greer; Ashraf Amlani; Bernadette Pauly; Charlene Burmeister; Jane A. Buxton

BackgroundThe Peer Engagement and Evaluation Project (PEEP) aimed to engage, inspire, and learn from peer leaders who represented voices of people who use or have used illicit substances, through active membership on the ‘Peeps’ research team. Given the lack of critical reflection in the literature about the process of engaging people who have used illicit substances in participatory and community-based research processes, we provide a detailed description of how one project, PEEP, engaged peers in a province-wide research project.MethodsBy applying the Peer Engagement Process Evaluation Framework, we critically analyze the intentions, strategies employed, and outcomes of the process utilized in the PEEP project and discuss the implications for capacity building and empowerment among the peer researchers. This process included: the formation of the PEEP team; capacity building; peer-facilitated data collection; collaborative data analysis; and, strengths-based approach to outputs.ResultsSeveral lessons were learned from applying the Peer Engagement Process Evaluation Framework to the PEEP process. These lessons fall into themes of: recruiting and hiring; fair compensation; role and project expectations; communication; connection and collaboration; mentorship; and peer-facilitated research.ConclusionThis project offers a unique approach to engaging people who use illicit substances and demonstrates how participation is an important endeavor that improves the relevance, capacity, and quality of research. Lessons learned in this project can be applied to future community-based research with people who use illicit substances or other marginalized groups and/or participatory settings.


CMAJ Open | 2014

A quantitative and qualitative evaluation of the British Columbia Take Home Naloxone program

Oluwajenyo Banjo MPHc; Despina Tzemis; Diana Al-Qutub; Ashraf Amlani; Sarah Kesselring; Jane A. Buxton


Harm Reduction Journal | 2015

Why the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia, Canada

Ashraf Amlani; Geoff McKee; Noren Khamis; Geetha Raghukumar; Erica Tsang; Jane A. Buxton


International Journal of Drug Policy | 2016

Collaborative transition to a methadone formulation change in British Columbia, Canada

Alissa M. Greer; Ashraf Amlani; Jane A. Buxton

Collaboration


Dive into the Ashraf Amlani's collaboration.

Top Co-Authors

Avatar

Jane A. Buxton

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Alissa M. Greer

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Alice L.-F. Mui

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Charlene Burmeister

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Despina Tzemis

BC Centre for Disease Control

View shared research outputs
Top Co-Authors

Avatar

Graham Ambrose

BC Centre for Disease Control

View shared research outputs
Top Co-Authors

Avatar

Raymond J. Andersen

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Andrew Deonarine

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Ariyanti S. Dewi

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge